Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Protein Engineering, Design & Selection : PEDS|January 13, 2009
Mutations at serine 37 in mouse guanylate kinase confer resistance to 6-thioguanineAndressa Ardiani, Amanda Goyke, Margaret E BlackFEMS Yeast Research|August 17, 2010
Vaccines based on whole recombinant Saccharomyces cerevisiae cellsAndressa Ardiani, Jack P Higgins, James W HodgeOncoimmunology|August 7, 2014
Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimensSofia R Gameiro, Andressa Ardiani, Anna Kwilas, et al.Oncoimmunology|February 6, 2014
Attacking malignant cells that survive therapy: Exploiting immunogenic modulationJames W Hodge, Anna Kwilas, Andressa Ardiani, et al.Cancer Research|June 3, 2009
Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivoMichi Fuchita, Andressa Ardiani, Lei Zhao, et al.Oncotarget|October 27, 2014
Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathwayAndressa Ardiani, Sofia R Gameiro, Anna R Kwilas, et al.Seminars in Oncology|May 19, 2012
The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitorsJames W Hodge, Andressa Ardiani, Benedetto Farsaci, et al.Journal of Translational Medicine|November 13, 2014
Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccineAnna R Kwilas, Andressa Ardiani, Renee N Donahue, et al.Oncotarget|August 29, 2015
A poxviral-based cancer vaccine the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer modelAnna R Kwilas, Andressa Ardiani, Ulrike Dirmeier, et al.Current Gene Therapy|March 6, 2012
Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapyAndressa Ardiani, Adam J Johnson, Hongmei Ruan, et al.Pageof 2